Hokkaido University | Library | HUSCAP | Advanced Search |
Hokkaido University Collection of Scholarly and Academic Papers >
CHP-MAGE-A4がんワクチン臨床試験患者における末梢血CD4+CD25+FOXP3+制御性T細胞比率の臨床的意義に関する研究 [論文内容及び審査の要旨]This item is licensed under:Creative Commons Attribution 4.0 International
OAI-PMH
(
junii2 ,
jpcoar_1.0
)
|
|||||||||||||||||||||||||||||||||||||||||||||||
|